SHE:300942 Revenue

Shenzhen Bioeasy Biotechnology had revenue of 49.34M CNY in the quarter ending March 31, 2025, with 35.28% growth. This brings the company's revenue in the last twelve months to 237.12M, up 3.15% year-over-year. In the year 2024, Shenzhen Bioeasy Biotechnology had annual revenue of 224.25M, down -11.75%.

Revenue (ttm)

237.12M

Revenue Growth

+3.15%

P/S Ratio

15.49

Revenue / Employee

493.99K

Employees

480

Market Cap

3.67B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	224.25M	-29.86M	-11.75%
Jan 1, 2024	254.11M	-432.79M	-63.01%
Jan 1, 2023	686.90M	89.36M	14.95%
Jan 1, 2022	597.54M	339.08M	131.20%
Dec 31, 2020	258.46M	19.28M	8.06%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings